Multiple barriers may stop high-risk individuals from getting access to an HIV drug that can reduce the subsequent risk of infection, according to a new research review.
Researchers outlined solutions that would help overcome barriers that make it harder for underserved populations to access pre-exposure prophylaxis (PrEP). The Centers for Disease Control and Prevention reported that nearly 40,000 people—about 43 percent of whom were black or Latino gay and bisexual men—received an HIV diagnosis in 2016.
